chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The client's sister-in-law reported that she developed a rash (generalized, raised, erythematous) on December 12, 2021 (four days after getting the second dosage of her COVID-19 vaccine series).  The client sought medical care and received a prescription for Prednisone.
Patient is not tired but looks tired; Patient experienced severe squeezing headache after receiving 2nd dose and still not going away; Patient reported pain in injection site; sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patient reported pain in injection site), HEADACHE (Patient experienced severe squeezing headache after receiving 2nd dose and still not going away), FATIGUE (Patient is not tired but looks tired) and PAIN IN EXTREMITY (sore left arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 006M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 24-Jan-2021, the patient experienced VACCINATION SITE PAIN (Patient reported pain in injection site) and PAIN IN EXTREMITY (sore left arm). On 20-Feb-2021, the patient experienced HEADACHE (Patient experienced severe squeezing headache after receiving 2nd dose and still not going away). On 02-Mar-2021, the patient experienced FATIGUE (Patient is not tired but looks tired).   The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. On 26-Jan-2021, VACCINATION SITE PAIN (Patient reported pain in injection site) and PAIN IN EXTREMITY (sore left arm) had resolved. At the time of the report, HEADACHE (Patient experienced severe squeezing headache after receiving 2nd dose and still not going away) and FATIGUE (Patient is not tired but looks tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient is treated with Advil.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Additional information added.
Have a slight headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Have a slight headache) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (Have a slight headache). At the time of the report, HEADACHE (Have a slight headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Facial rash-swelling, leakage, redness, flaking.(Dermatitis) Folliculitis-upper lip(likely bacterial etiology with infectious nature. Seen on 3/22/21-Methodist healthcare Minor Emergency, Seen 3/24/21. Dermatology, Seen 3/24/1921-Regional One Health. Allergic reaction from COVID vaccine. Medication prescribed-Medrol(pak):4 mg orally daily clindamycin, desonide, triamcinolone
I had headache, slight fever, congestive, cough and fatigue.  These lasted for about a week. I also had SOB that lasted for about 2 weeks. I found out that I had blood clots in my lungs because of Covid-19. I tested positive for COVID-19 on Jan 6th, I contacted my doctor about this. They did a lung x-ray and a CT angiogram, that showed the blood clots in my lungs.
Two days in bed: high fever, sweating/chills, headache, nausea, sever leg muscle pain and cramps.  After two days of this, I then had a severe swollen knee. I was given 5 day course of steroids for the inflammation.
Itchy skin. When scratch skin turns red and bumps appear, itches more. Benadryl helps relieve itchiness. Redness goes away within a few hours if not scratched. Cortizone 10 helps relieve itchiness. Itchiness is all over body, though not all at once. Random spots will be itchy, then a different spot later. Itchiness started about 10 days after booster. Visited doctor the next day. Also started a new probiotic around that time. Immediately stopped taking that. Suggested claritin daily, benadryl as needed, and once a day singulair for a week. Symptoms somewhat improved but did not go away. Benadryl was most helpful. A week later (10 days after first symptoms), stopped singulair and started with prednisone. Probiotic was unlikely bc ongoing reaction. Stopped all other vitamins, still taking sertraline. 6 day course starting with 30mg decreasing 5mg each day. Prednisone didn't really seem to help. Itchiness was worst just before bed. Had to take benadryl + pain killer (tylenol while on prednisone, otherwise ibuprofen) to get to sleep. Able to sleep through the night with that. Prednisone course is done now and still itchy. Have another dr appointment tomorrow (~2.5 weeks after symptoms started, 4 weeks after booster shot).
Total agony; Could not put weight on her left foot; Could not lift her head off the pillow; Could not move without extreme pain; Felt every muscle in her body hurt,could not move without extreme pain; Severe reaction post first dose; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Severe reaction post first dose), PAIN (Total agony), LIMB DISCOMFORT (Could not put weight on her left foot), HEAD DISCOMFORT (Could not lift her head off the pillow) and PAIN (Could not move without extreme pain) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced ADVERSE REACTION (Severe reaction post first dose). On 21-Feb-2021, the patient experienced PAIN (Total agony), LIMB DISCOMFORT (Could not put weight on her left foot), HEAD DISCOMFORT (Could not lift her head off the pillow), PAIN (Could not move without extreme pain) and MYALGIA (Felt every muscle in her body hurt,could not move without extreme pain). At the time of the report, ADVERSE REACTION (Severe reaction post first dose), PAIN (Total agony), LIMB DISCOMFORT (Could not put weight on her left foot), HEAD DISCOMFORT (Could not lift her head off the pillow), PAIN (Could not move without extreme pain) and MYALGIA (Felt every muscle in her body hurt,could not move without extreme pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Additional-Contact info updated.
Large red swelling around injection sight, hard, hot, growing, fever, irritability, obvious pain.
This spontaneous report was received from a licensed practical nurse refers to multiple unspecified patients of unknown age. On an unknown date, the patients may have been vaccinated with an improperly stored doses of RECOMBIVAX HB lot # K026666, 22-OCT-2016, L016427 13-APR-2017. No adverse effects reported. Temperature 1.7 degree Centigrade, time frame 19 minutes. This is one of the two reports received from the same reporter. Additional information has been requested.
Spongiotic Dermatitis on arms, chest, face, neck, inner ears,  inner nostrils, back of neck, scalp, and armpits.
Initial unsolicited report received from a non-healthcare professional on 19-Feb-2018. This case involves a 66-year-old female patient, who was vaccinated with 0.5 ml single dose of FLUZONE QIV (batch number, expiration date, dose series and site of administration were not reported), intramuscularly on 26-Oct-2017. The patient developed food allergies and was allergic past to multiple medications such as penicillin, RELAFEN, ULTRAM, VICODIN, PERCOCET and MS CONTIN. The patient medical history includes osteoarthritis, osteopenia, fibromyalgia and sleep apnea, asthma and gastroesophageal reflux disease. The patient's concomitant medication was not reported. On an unknown date, few days post vaccination the patient developed pain, itching, feeling as if bugs were crawling over her body, widespread over the body. The symptoms came and gone, but have not ceased. Patient's lab test and corrective treatment was not reported. At the time of report, outcome of events was not recovered. List of documents held by sender: none.
? BREAST PROBLEM     inflamed R breast x3 with pain with redness      Subjective:    HPI: Patient is a 49 year old female complaining of right  Breast pain x 3 days.  Fever and chills lateral night. No redness or nipple discharge noted.  Patient had last mammogram x 2 years ago .  Last Mammogram Test:  6/19/19 (which was normal) Patient reports history of dense breast tissue.   Assessment: RIGHT MASTODYNIA     PLAN:  Orders Placed This Encounter ? MAMMO BILAT DX SEQUENTIAL W OR WO COMPUTER AIDED DETECTION ANALYSIS     Reason: right  Breast pain with mass that measures approximately 10 x 6 centimeter at 8 o clock  Radiologist: Follow Sequential Breast Imaging Orders Policy and Procedures.     Order Specific Question:   Is the Patient Pregnant?     Answer:   No     Order Specific Question:   Result Release to patient?     Answer:   Immediate ? US RIGHT BREAST LTD DX, SEQUENTIAL     Result Release to patient?->Immediate Dr. ordered  exam change, 05/27/2021 @ 14;28 ? Ketorolac Inj 30 mg (TORADOL) ? Dicloxacillin 500 mg Oral Cap     Sig: Take 1 capsule by mouth 4 times a day for 10 days     Dispense:  40 capsule     Refill:  0     Order Specific Question:   Is this medication for a workers' compensation condition?     Answer:   No     MEDICAL DECISION MAKING:   Radiology ordered for patient.  Discussed possible infection, will treat with antibiotics in the meantime. Recommend warm compressions and follow up with radiology.  Once patient gets appointment, she is to set a primary care provider appointment to discuss results.  Patient instructed to return to the urgent care / emergency department if symptoms worsen or fail to improve as anticipated.    I have discussed the risks, benefits, alternative to treatments that will be rendered. The patient is competent and understands and agrees to comply with treatment plans. The patient understands the risks of noncompliance and the consequences that may occur.    Electronically signed by: PA 5/27/2021 7:24 PM
Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023; No adverse event; Patient received expired vaccine that was administered on 15-March-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine that was administered on 15-March-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) in a 35-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 060B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Mar-2023, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine that was administered on 15-March-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine that was administered on 15-March-2023), PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine that was administered on 15-March-2023) and PRODUCT STORAGE ERROR (Vaccine expired on 26Feb2023, moved to refrigerator on 14Mar2023 and administered on 15Mar2023).    No concomitant medications were reported.  Vial size was reported as 10 dose vial. The vial was initially stored in the refrigerator on 14-MAR-2023  The vial did not undergo any temperature excursions. It was reported that HCP stated the expired Moderna COVID-19 monovalent vaccine was administered to approximately 75-125 patients on 15-MAR-2023. There was potentially a second lot number that was expired and was administered to patients on 3-MAR-2023, but HCP did not have any details on this event at this time. The second potential lot was confirmed to not be used. There are a total of 82 patients involved. HCP wants to know if the vaccine administered on 15-MAR-2023 would be considered valid for the patients.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-716065 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-716065:Master Case
Patient called with concerns after getting flu shot.  Experienced redness from shoulder to elbow, warm to touch, fever and chills for one day.
HEART RATE HIT 80, NORMALLY 60; MOVING A LOT AND VERY LITTLE DEEP SLEEP BETWEEN 2AM TO 4AM; TEMPERATURE HIGHER BY 2 FAHRENHEIT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-APR-2021 on an unspecified site for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On APR-2021, the patient experienced heart rate hit 80, normally 60. On APR-2021, the patient experienced moving a lot and very little deep sleep between 2am to 4am. On APR-2021, the patient experienced temperature higher by 2 Fahrenheit. Laboratory data included: Body temperature (NR: not provided) higher by 2 F, and Heart rate (NR: not provided) increased to 80 (units not specified) from 60 (units not specified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the temperature higher by 2 Fahrenheit, heart rate hit 80, normally 60 and moving a lot and very little deep sleep between 2am to 4am was not reported. This report was non-serious.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL (unknown route and strength) Lot # K009482 with expiry date of 06-MAR-2017 or lot # K010574 with expiry date of 08-APR-2017. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
pain at injection site; Arm soreness / pain and sore left arm; was sleepy from the soreness; was reconstituted and left out at room temperature for 1 hour then administered.; was reconstituted and left out at room temperature for 1 hour then administered; This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th November 2021, the patient received the 1st dose of Shingrix. On 15th November 2021, unknown after receiving Shingrix, the patient experienced incorrect storage of drug and product administration error. On an unknown date, the patient experienced injection site pain, pain in arm and sleepiness. On an unknown date, the outcome of the injection site pain and pain in arm were recovered/resolved and the outcome of the sleepiness, incorrect storage of drug and product administration error were unknown.   It was unknown if the reporter considered the injection site pain, pain in arm and sleepiness to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case who was also a Pharmacologist. The patient received the first dose of Shingrix in the left arm. Before administration of the first dose, the vaccine was reconstituted and drawn up into a syringe but left out in syringe at room temperature (about 74 Fahrenheit) for 1 hour then administered, which led to incorrect storage of drug and product administration error. The patient experiencing pain at the injection site and arm soreness that lasted approximately 2 to 3 days. It was unknown if symptoms have resolved.  Limited demographics provided. Did not consent to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021236254:same reporter - FU1 - deleted.
On 10/09/2021 - 2 days after- I started itching, and at first, I thought I was getting hives on my wrist and on my lower arms and it started spreading and looked like I had a combination of measles and chicken pox, and its open sores right now because I have scratched so much. It's just a really severe case of itchy hives. I wondered at one point if it was shingles, but shingles hurt and these don't, they just itch really bad. The doctor put me on two different courses of Prednisone and Hydroxyzine and Triamcinolone cream and Bactroban.
I?ve been having muscle spasms in my neck and back. On today, I feel tingling in my fingers and on my feet. Pain in my neck and back. I have received three massages, got an adjustment at the chiropractor, taking Diclofenac and Baclofen. The medicines are not working nor making me sleepy.  FYI the pharmacist said that she didn?t have anymore is the Pfizer but then she kept going back and forth on whether she had it or not. She finally said yes that there was enough in the bottle for one person.
numbness in left hand side of his face/ numbness in neck/numbness in arm; discomfort in left hand side of his face; discomfort in neck; discomfort in arm; This feeling of numbness quickly became more uncomfortable as the days progressed; He also elected not to take his second dose; The lymph nodes in his neck also swelled to a level which made it uncomfortable for him to swallow; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in left hand side of his face/ numbness in neck/numbness in arm), FACIAL DISCOMFORT (discomfort in left hand side of his face), MUSCULOSKELETAL DISCOMFORT (discomfort in neck), LIMB DISCOMFORT (discomfort in arm) and HYPOAESTHESIA (This feeling of numbness quickly became more uncomfortable as the days progressed) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (numbness in left hand side of his face/ numbness in neck/numbness in arm), FACIAL DISCOMFORT (discomfort in left hand side of his face), MUSCULOSKELETAL DISCOMFORT (discomfort in neck), LIMB DISCOMFORT (discomfort in arm), HYPOAESTHESIA (This feeling of numbness quickly became more uncomfortable as the days progressed), PRODUCT DOSE OMISSION ISSUE (He also elected not to take his second dose) and LYMPHADENOPATHY (The lymph nodes in his neck also swelled to a level which made it uncomfortable for him to swallow). At the time of the report, HYPOAESTHESIA (numbness in left hand side of his face/ numbness in neck/numbness in arm), FACIAL DISCOMFORT (discomfort in left hand side of his face), LIMB DISCOMFORT (discomfort in arm), HYPOAESTHESIA (This feeling of numbness quickly became more uncomfortable as the days progressed) and LYMPHADENOPATHY (The lymph nodes in his neck also swelled to a level which made it uncomfortable for him to swallow) outcome was unknown and MUSCULOSKELETAL DISCOMFORT (discomfort in neck) and PRODUCT DOSE OMISSION ISSUE (He also elected not to take his second dose) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Scan: lymph nodes were 22mm by  18mm in size lymph nodes were 22mm by  18mm in size.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Immediately after administration patient had extreme pain in upper arm at the site of the injection. The pain was immediate and has lasted for months.
After almost two days of just minor pain in the arm area, the vaccination site became extremely red with pain  and swollen and very hot. The area affected was approximately  7 inches by 5 inches and was like that for almost three days. For the last two days it has been itching in that area,still is on and off. I did not take any medications for it. I did apply ice packs to the area fairly regularly and even heat a few times.
Immediately post vax, the pt experienced an injection site rash. No treatment was given. The most recent information received reports the outcome of the event as unresolved.
pt recv vax 20OCT97 & OCT97 pt devel a red, swollen, hot area 3 inches in diameter around inj site;
Very light soreness at injection site; This is a spontaneous report from a contactable consumer. A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E13248), via an unspecified route of administration from 16Jan2021 at 09:15 on his right arm at a single dose for COVID-19 immunization. Medical history included hypertension (successfully controlled with 10 mg lisinopril) from an unknown date and unknown if ongoing. Concomitant medications included fish oil, glucosamine and lisinopril. The patient experienced very light soreness at injection site on 16Jan2021 at 10:00. The patient did not receive treatment for the event. The outcome of the event was unknown.